Monday, 24 April 2017

Most anti-inflammatory agents are unsafe

Dr. Weeks’ Comment:  First do no harm (“Premium non nocere”)  is a professional creed which all too many doctors have ignored or forsaken.  Prescription patented profitable pHARMaceutical drugs do work – they attain their goals –  but frequently at too high a cost since typically, side-effects often exceed the treatment goals.

Now we learn that the commonly taken anti-inflammatory agent Ibuprofen causes an increased risk of heart attack.   Avoid it.  But you DO want to take anti-inflammatory agents… and we have the solution  – drink the whole crushed organic anti-inflammatory seed drink CORE or SOUL. 

 

Non-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case–time–control study
24 December 2016
AIM    Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used and have been associated with increased cardiovascular risk. Nonetheless, it remains unknown whether use of NSAIDs is associated with out-of-hospital cardiac arrest (OHCA).

Methods and results     From the nationwide Danish Cardiac Arrest Registry, all persons with OHCA during 2001–10 were identified. NSAID use 30 days before OHCA was categorized as follows: diclofenac, naproxen, ibuprofen, rofecoxib, celecoxib, and other. Risk of OHCA associated with use of NSAIDs was analysed by conditional logistic regression in case–time–control models matching four controls on sex and age per case to account for variation in drug utilization over time. We identified 28 947 persons with OHCA of whom 3376 were treated with an NSAID up to 30 days before OHCA. Ibuprofen and diclofenac were the most commonly used NSAIDs and represented 51.0% and 21.8% of total NSAID use, respectively. Use of diclofenac (odds ratio [OR], 1.50 [95% confidence interval (CI) 1.23–1.82]) and ibuprofen [OR, 1.31 (95% CI 1.14–1.51)] was associated with a significantly increased risk of OHCA. Use of naproxen [OR, 1.29 (95% CI 0.77–2.16)], celecoxib [OR, 1.13 (95% CI 0.74–1.70)], and rofecoxib (OR, 1.28 [95% CI 0.74–1.70)] was not significantly associated with increased risk of OHCA; however, these groups were characterized by few events.
Conclusion

Use of non-selective NSAIDs was associated with an increased early risk of OHCA. The result was driven by an increased risk of OHCA in ibuprofen and diclofenac users.

Share This Post

Dr. Weeks’ Comment:  First do no harm (“Premium non nocere”)  is a professional creed which all too many doctors have ignored or forsaken.  Prescription patented profitable pHARMaceutical drugs do work – they attain their goals –  but frequently at too high a cost since typically, side-effects often exceed the treatment goals. Now we learn that…
&source=WeeksMD">
  • Get Updates

    newsletter code

    WELCOME!

    The information contained on these web pages is derived from Dr. Weeks’ years of clinical experience and his review of scientific literature. However, these ideas and information are for your education and entertainment only. They are positively not intended to be a substitute for careful medical evaluation and treatment by a competent, licensed personal health care professional. Dr. Weeks and his associates do not recommend changing any current medications or adding any new therapies without personally consulting a fully qualified physician. Dr. Weeks and his staff specifically disclaim any liability arising directly or indirectly from information contained on these Web pages.

    Varying and even conflicting views are held by other segments of the medical profession. The information presented on these Web pages is intended to be educational and entertaining in nature and is not intended as a basis for diagnosis or treatment. This information is current at the time of posting on the World Wide Web, and is published and distributed as a courtesy to the public.